Home
>
About Us
> Why Daewoong
Daewoong takes No.1 position possessing 8 products of which sales is over 10 bil won.
(Source : Korean Pharmacist News)
Angiotensin-II Antagonist
Olmetec
®
Antidiabetics
Diabex
®
Nootropics
Gliatilin
®
Gastroprokinetic
Gasmotin
®
Liver Dysfunction
Ursa
®
Antifungal Agent
Plunazole
®
NSAID
Airtal
®
Product Name
(Launching Date)
Therapeutic class
Sales
M/P*
Ursa
BILE THERAPY&CHOLAGOGUES
(A05A)
50
1
Plunazole
SYST ANTIFUNGAL AGENTS (J02A)
14
1
Nicostop
Antismoking Products(N07B)
16
1
Olmetec
Angiotensin-II Antagonist (C09C/D)
32.1
5
Diabex
Oral Antidiabetics
(A10B)
15.2
4
Gliatilin
Nootropics
(N06D)
22.7
2
Gasmotin
Gastroprokinetics
(A03F)
30.5
1
Tiropa
Plain Antispasmodics & Anticholinergics (A03A)
5.7
1
Bearse
Digestive Enzymes (A09A)
31.8
2
Smecta
Intestinal Absorbant Antidiarrheals (A07B)
8.4
1
Airtal
Antirheumatic Nonsteroid
(M01A)
11.5
2
Erdos
Expectorants
(R05C)
7
2
Alleloc
Antihistamin
(R06A)
5
4
Botox
Muscle Relaxant Peripheral
(M03A)
2.7
2
Market Position of Daewoong
Sales in Mil. USD
Source: IMS, ~MAT 4Q2006
Daewoong Pharm
Daewoong Bio
R&P Korea
DMD
Daewoong International
Daewoong Life Science
Daewoong America
IDS&Trust
Ezmedicom
Insung Info
Healience
MDwell
Market Position of Daewoong
